Because IL-4 is a key factor for inducing IgE isotype switching in B cells and IFN-γ inhibits IgE secretion through the antagonistic effect of Th2 cytokines in AD, imbalance of the Th1/Th2 immune responses is restored after oral administration of ST-miRTLR8. Here, IGHE is linked to Alzheimer disease.